相关实验视频

Updated: Jan 17, 2026

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

奇达胺作为对外围T细胞淋巴瘤的维持治疗的有效性和安全性:一个多中心的现实研究

Wenjing Jiang^1,2, Xiyuan Zhang², Wei Song³

¹School of Medcine, Qingdao University, Qingdao, China.

Frontiers in oncology

|September 18, 2025

概括

奇胺维护疗法在周围T细胞淋巴瘤 (PTCL) 患者中显示出有效性和良好的耐受性. 维持前的缓解状态对于结果至关重要,这表明了顺序诱导-维持治疗的价值.

科学领域:

在瘤学瘤学.
血液学血液学血液学
药理学药理学是指药理学的学科.

背景情况:

周围T细胞淋巴瘤 (PTCL) 具有显著的复杂性和可变性.
传统化疗对PTCL患者提供了不良的治疗结果.

研究的目的:

探索奇达胺单疗的有效性和安全性,作为PTCL化疗后的维护疗法.
评估前维护缓解状态对治疗结果的影响.

主要方法:

一项涉及69名PTCL患者的研究,他们接受了基达胺维持疗法 (15-30毫克每周两次).
卡普兰-梅尔生存分析用于评估整体生存 (OS) 和无进展生存 (PFS).

主要成果:

无进展生存期 (mPFS) 的中位数为54.8个月.
在47.8%的患者中实现了完全响应 (CR);基线CR预测了优异的PFS.
中性是最常见的3/4级不良事件 (20.3%),没有与治疗相关的死亡事件.

结论:

奇胺单疗法在PTCL维护中显示出有效性和良好的耐受性.
维护前缓解状态是PFS的关键预后指标.
诱导-维护顺序模型提供了显著的好处,改善了预后,降低了复发风险.

关键词:

青胺是一种胺.有效性有效性.维护疗法维护疗法周围T细胞淋巴瘤在安全方面,安全是安全的.

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

相关概念视频

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.